Therapeutic targeting of tumor-associated macrophages

Area of Science:

• Immunology
• Oncology
• Cell Biology

Background:

• Tumor-associated macrophages (TAMs) are abundant in the tumor microenvironment and linked to poor prognosis in many cancers.
• TAMs promote tumor development via angiogenesis and immune suppression, exhibiting significant phenotypic heterogeneity.
• Current therapeutic strategies primarily focus on general TAM depletion, targeting axes like CSF-1/CSF-1R or CCR2/CCL2 signaling.

Purpose of the Study:

• To review the functions and heterogeneity of TAMs.
• To provide an overview of clinical development for pan-targeting TAM strategies.
• To discuss emerging strategies for targeting specific TAM subsets in anti-tumor immunotherapy.

Main Methods:

• Literature review of TAM functions and heterogeneity.
• Analysis of current clinical development for general TAM-targeting therapies.
• Exploration of novel strategies for subset-specific TAM targeting.

Main Results:

• General TAM depletion strategies have shown limited clinical success despite preclinical efficacy.
• Significant heterogeneity exists within TAM populations in the tumor microenvironment.
• New approaches focusing on specific TAM subsets are emerging for cancer immunotherapy.

Conclusions:

• Targeting specific TAM subsets holds promise for overcoming the limitations of current broad-spectrum therapies.
• Understanding TAM heterogeneity is crucial for developing effective, targeted anti-cancer immunotherapies.
• Future research should focus on precise targeting of TAM subsets to enhance anti-tumor immune responses.